Session Description:

A non-promotional symposium, organized by GSK, discussing evidence on how current clinical tools and kidney biopsies can be utilized for effective management of lupus nephritis throughout the patient journey. The opening presentation will introduce diagnostic biopsy as the current gold standard tool. This presentation will be followed by a discussion about various clinical tools to assess response to therapy and therapy-withdrawal decisions. The utility of repeat biopsies at various decision points will be explored.